What is the role of chemotherapy in the treatment of non–small cell lung cancer (NSCLC)?

Updated: Jul 15, 2021
  • Author: Winston W Tan, MD, FACP; Chief Editor: Nagla Abdel Karim, MD, PhD  more...
  • Print

At present, chemotherapy alone has no role in potentially curative therapy for NSCLC. Some trials have shown a survival benefit with adjuvant chemotherapy (ie, chemotherapy given after surgery) in resected stage IIA, IIB, and IIIA NSCLC, with a survival advantage of 5-10%. [107, 108] However, adjuvant chemotherapy in elderly patients with resected stage IIIA NSCLC is not associated with survival advantage. [109]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!